213 related articles for article (PubMed ID: 28619026)
81. Beclin1 circulating level as predictor of carotid intima-media thickness in patients with type 2 diabetes mellitus.
Naguib M; Tarabay A; ElSaraf N; Rashed L; ElMeligy A
Medicine (Baltimore); 2021 Jul; 100(28):e26630. PubMed ID: 34260553
[TBL] [Abstract][Full Text] [Related]
82. A U-shaped relationship between ankle-brachial index and carotid intima-media thickness in a Chinese population of Inner Mongolia.
Wang Y; Li J; Guo X; Zhao D; Hu D; Wei Y; Hou L; Xu Y; Ma Y
Int Angiol; 2011 Oct; 30(5):451-7. PubMed ID: 21804484
[TBL] [Abstract][Full Text] [Related]
83. Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women.
Xu Y; Ma X; Pan X; He X; Xiao Y; Bao Y
Cardiovasc Diabetol; 2018 Nov; 17(1):143. PubMed ID: 30424752
[TBL] [Abstract][Full Text] [Related]
84. Association of Time in Range levels with Lower Extremity Arterial Disease in patients with type 2 diabetes.
Li J; Li Y; Ma W; Liu Y; Yin X; Xie C; Bai J; Zhang M
Diabetes Metab Syndr; 2020; 14(6):2081-2085. PubMed ID: 33137566
[TBL] [Abstract][Full Text] [Related]
85. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Taniguchi M; Yoshida H; Tokumoto M; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Kitazono T
Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
[TBL] [Abstract][Full Text] [Related]
86. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Masutani K; Ooboshi H; Kitazono T
Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562
[TBL] [Abstract][Full Text] [Related]
87. Fibroblast growth factor 23 serum level in type 2 diabetic italian subjects with peripheral arterial disease and critical limb ischemia.
Biscetti F; Straface G; Pitocco D; Angelini F; Tinelli G; Landolfi R; Flex A
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):4048-4054. PubMed ID: 27775794
[TBL] [Abstract][Full Text] [Related]
88. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
[TBL] [Abstract][Full Text] [Related]
89. Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
Panwar B; Jenny NS; Howard VJ; Wadley VG; Muntner P; Kissela BM; Judd SE; Gutiérrez OM
Stroke; 2015 Feb; 46(2):322-8. PubMed ID: 25563643
[TBL] [Abstract][Full Text] [Related]
90. Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure.
Isakova T; Houston J; Santacruz L; Schiavenato E; Somarriba G; Harmon WG; Lipshultz SE; Miller TL; Rusconi PG
Pediatr Nephrol; 2013 Oct; 28(10):2035-42. PubMed ID: 23740037
[TBL] [Abstract][Full Text] [Related]
91. Associations of serum fibroblast growth factor 23 levels with obesity and visceral fat accumulation.
Hu X; Ma X; Luo Y; Xu Y; Xiong Q; Pan X; Xiao Y; Bao Y; Jia W
Clin Nutr; 2018 Feb; 37(1):223-228. PubMed ID: 28027796
[TBL] [Abstract][Full Text] [Related]
92. Association of Circulating Osteopontin Levels With Lower Extremity Arterial Disease in Subjects With Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study.
Eleftheriadou I; Tsilingiris D; Tentolouris A; Mourouzis I; Grigoropoulou P; Kapelios C; Pantos C; Makrilakis K; Tentolouris N
Int J Low Extrem Wounds; 2020 Jun; 19(2):180-189. PubMed ID: 32041444
[TBL] [Abstract][Full Text] [Related]
93. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis.
Amor AJ; Catalan M; Pérez A; Herreras Z; Pinyol M; Sala-Vila A; Cofán M; Gilabert R; Ros E; Ortega E
Atherosclerosis; 2016 Apr; 247():161-9. PubMed ID: 26921744
[TBL] [Abstract][Full Text] [Related]
94. Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study.
Lin CH; Chang CK; Shih CW; Li HY; Chen KY; Yang WS; Tsai KS; Wang CY; Shih SR
Osteoporos Int; 2019 Nov; 30(11):2289-2297. PubMed ID: 31384956
[TBL] [Abstract][Full Text] [Related]
95. Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.
Niu Y; Zhang W; Yang Z; Li X; Wen J; Wang S; Zhang H; Wang X; Zhou H; Fang W; Qin L; Su Q
BMC Cardiovasc Disord; 2015 Aug; 15():86. PubMed ID: 26260869
[TBL] [Abstract][Full Text] [Related]
96. The Association Between Femoral Artery Intima-Media Thickness and Serum Glucagon-Like Peptide-1 Levels Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus.
Le TD; Nguyen NPT; Nguyen ST; Nguyen HT; Tran HTT; Nguyen THL; Nguyen CD; Nguyen GT; Nguyen XT; Nguyen BD; Trinh ST; Ngo TA; Do BN; Luong TC
Diabetes Metab Syndr Obes; 2020; 13():3561-3570. PubMed ID: 33116707
[TBL] [Abstract][Full Text] [Related]
97. Serum adipocyte fatty acid-binding protein levels are associated with peripheral arterial disease in women, but not men, with type 2 diabetes mellitus.
Ding M; Shi JY; Xing YZ; Sun B; Fang QH; Zhang JY; Zhang QM; Chen LM; Yu DM; Li CJ
J Diabetes; 2018 Jun; 10(6):478-486. PubMed ID: 28303680
[TBL] [Abstract][Full Text] [Related]
98. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.
Eleftheriadou I; Grigoropoulou P; Kokkinos A; Mourouzis I; Perrea D; Katsilambros N; Sfikakis PP; Tentolouris N
J Diabetes Complications; 2017 Mar; 31(3):599-604. PubMed ID: 27899247
[TBL] [Abstract][Full Text] [Related]
99. Association of indoxyl sulfate with fibroblast growth factor 23 in patients with advanced chronic kidney disease.
Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
Am J Med Sci; 2014 May; 347(5):370-6. PubMed ID: 24051956
[TBL] [Abstract][Full Text] [Related]
100. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones.
Taylor EN; Hoofnagle AN; Curhan GC
Clin J Am Soc Nephrol; 2015 Apr; 10(4):667-75. PubMed ID: 25623233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
